DNA and RNA Sample Preparation Market Size to Exceed USD 3,356.8 Mn by 2032

The DNA and RNA Sample Preparation Market, estimated at USD 2,262.2 Mn in 2025, is expected to exhibit a CAGR of 5.8% and reach USD 3,356.8 Mn by 2032.

The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.

The advent in biotechnological systems is expected to provide lucrative growth opportunities for players. Thus, key market players are focused on adopting growth strategies such as partnerships and collaborations, which will drive the global DNA and RNA sample preparation market. For instance, on May 13, 2020, Cellectricon (Molndal), a Sweden–based pharmaceutical company, collaborated with StressMarq Biosciences, a Canada-based life sciences reagents supplier, for development of next generation reagents and assays to advance in neurodegenerative diseases. Such collaborative efforts and initiatives to identify therapies for difficult-to-treat illnesses can boost growth of the global DNA and RNA sample preparation market.

Global DNA and RNA Sample Preparation Market – Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways:  by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a positive impact on the global DNA and RNA sample preparation market. This is because the newer research and development activities were being carried out for efficient RNA separation. For instance, according to article published by Journal Scientific Reports, on October 6, 2020, a newer method was developed that can take just 40 min to extract RNA from 10 samples. This method can be used in COVID-19 detection methods such as RT-q PCR (Real-Time Quantitative Reverse Transcription PCR) to process nasopharyngeal swab. Such technique can reduce time taken for analysis and can work in any molecular diagnostic laboratory. Its results were found to be comparative to the commercially used methods.  

Global DNA and RNA Sample Preparation Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, on March 24, 2022, Miroculus, Inc., a U.S.-based biotechnology company, launched Miro Canvas, a digital microfluidics platform to automate complex next-generation sequencing (NGS) protocols. It is simple, automatic, and miniaturize complex NGS library prep, that improves library consistency and eliminating the need for robotics. It has advantage over conventional liquid handling systems that are expensive, not suitable for on-demand sequencing and manual preparation. The automation enabled by the platform is well-suited for laboratories that do not run a high volume of sequencing samples and want improved control over sample processing.

Browse 35 Market Data Tables and 33 Figures spread through 155 Pages and in-depth TOC on “Global DNA and RNA Sample Preparation Market”, By Product Type (Workstations, Kits (DNA Sample Preparation, RNA Sample Preparation), Reagents & Consumables), By Application (Clinical Testing, Diagnostic Testing, Research Applications), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes, Forensic Science Laboratories, Contract Research Organizations), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/dna-and-rna-sample-preparation-market-3620

Key Takeaways of the Global DNA and RNA Sample Preparation Market:

• The global DNA and RNA sample preparation market is expected to exhibit a CAGR of 5.8 %during the forecast period. Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in March 3, 2020, Fluidigm Corporation, a U.S.-based biotechnology research company, partnered with Next Gen Diagnostics (NGD), a U.S.-based molecular diagnostic service company to announce an exclusive agreement that enables NGD to utilize Fluidigm Juno system for pathogen whole genome sequencing sample preparation in exchange of milestone payments starting in 2020 and additional revenue for over five years to Fluidigm Corporation. This agreement enables Fluidigm and NGD to offer hospitals and public health laboratories whole genome sequencing at unprecedentedly low cost, enabling detection of pathogen transmission and surveillance of the spread of drug-resistant pathogens.
• Among region, North America is expected to be the dominant region in the global DNA and RNA sample preparation market, owing to the increasing launch of products. For instance on July 31, 2020, OraSure Technologies, Inc., a U.S.-based medical device company, announced that its product OMNIgene ORAL (OM-505) saliva collection device received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for use in Clinical Reference Laboratory (CRL), one of the privately held clinical testing laboratories in the U.S., for COVID-19 testing.

Major players operating in the global DNA and RNA sample preparation market include, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc.